Skip to content
Research Article Open access CC BY 4.0

Rivaroxaban: Compatibilty with Pharmaceutical Excipients using DSC and FTIR Spectrophotometry

Rama Rao Nadendla, J. Satynarayana, Jaya Krishna Burri

Journal of Pharmaceutical Research International · pp. 43–50 · Published 18 Feb 2022

10.9734/jpri/2022/v34i12A35554

Abstract

Rivaroxaban (RN) is a recently developed potent oral anticoagulant. The aim of the present study envisages compatibility studies of rivaroxaban with crospovidone, sodium startch glycolate, magnesium stearate, talc, microcrystalline cellulose, aerosil, HPMC K100 M, croscarmellose sodium using Differential scanning calorimeter and FTIR spectrophotometer. DSC thermograms, of rivaroxaban and physical mixture of individual pharmaceutical excipient, exhibited the range of transition of the drug in between 224ºC and 232ºC. The FTIR graphs showed that the wave numbers of rivaroxaban, matched with all the chosen pharmaceutical excipients combinations. Thus the DSC and FTIR studies showed that RN was not interactive with selected pharmaceutical excipients and can be carried forward for further studies.

Rivaroxaban FTIR DSC thermal compatibility pharmaceutical excipients

Cited by 20

HPTLC method for simultaneous determination of rivaroxaban and its aminomethyl process impurity/metabolite

Amit Shimpi, Bhatu Patil, Kunal Bhadane · Accreditation and Quality Assurance · 2025

Rivaroxaban loaded lipid carriers integrating EPA oil: A novel paradigm in drug repurposing for navigating colon targeted oral treatment for ulcerative colitis

Walaa A. El-Dakroury, Abdelrahman R. Said, Sherif S. Abdel Mageed · Journal of Drug Delivery Science and Technology · 2025

Enhancing skin residence time of penciclovir for the treatment of cold sores: formulation and characterization of controlled release microsponges

Rajesh Devani, Sohil Chauhan, Kiran Dudhat · Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

FORMULATION, CHARACTERIZATION AND PHARMACOKINETIC EVALUATION OF RIVAROXABAN-CITRIC ACID COCRYSTALS WITH ENHANCED SOLUBILITY, STABILITY AND BIOAVAILABILITY

DEEPAK KULKARNI, SANJAY PEKAMWAR, PRASHANT TANDALE · International Journal of Applied Pharmaceutics · 2025

TO FORMULATE AND STUDY THE RELEASE KINETICS OF RIVAROXABAN TABLETS USING CO-PROCESSED EXCIPIENTS

KOLWALKAR S, KENY S, SAWAIKAR L · Asian Journal of Pharmaceutical and Clinical Research · 2025

Compatibility Study of Fenofibrate with Some Common Excipients and Their Effect on Solid Doge Formulation Development

Prajakta Arun Pawar, Vivek Ranjan Sinha, Ashok Kumar Yadav · Journal of Modern Biology and Drug Discovery · 2024

DESIGN AND EVALUATION OF RIVAROXABAN EFFERVESCENT GRANULES

Department of Pharmaceutical Chemistry, Chalapathi Institute of Pharmaceutical Sciences, Chalapathi Nagar, Lam – 522 034, Guntur, Andhra Pradesh, India, Rama Rao Nadendla, Sandeep Kanna · INDIAN DRUGS · 2024

Showing 9 of 20 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

12

Page views

0

PDF downloads

0

Outbound clicks

20

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.